Latin America Cutaneous Oncology Management (LACOM) II: A Practical Algorithm for Managing Skin Toxicities in Oncology Patients.

IF 2.2 4区医学 Q3 DERMATOLOGY

Journal of Drugs in Dermatology Pub Date : 2026-07-01 DOI:10.36849/JDD.9768

Daniel Alcalá Pérez, Anneke Andriessen, Vanja Adzovic, Sebastian Andreani, Herbert Cárdenas, Marcela Moreno, Daniel Motola Kuba, Julia Riganti, José Enrique Ollague, Alejandra Toquica, Mario Lacouture

{"title":"Latin America Cutaneous Oncology Management (LACOM) II: A Practical Algorithm for Managing Skin Toxicities in Oncology Patients.","authors":"Daniel Alcalá Pérez, Anneke Andriessen, Vanja Adzovic, Sebastian Andreani, Herbert Cárdenas, Marcela Moreno, Daniel Motola Kuba, Julia Riganti, José Enrique Ollague, Alejandra Toquica, Mario Lacouture","doi":"10.36849/JDD.9768","DOIUrl":null,"url":null,"abstract":"Background: Anticancer treatments are associated with cutaneous adverse events (cAEs) that can severely impact patients' quality of life (QoL) and interfere with treatment outcomes. LACOM aims to support clinicians in preventing and managing cAEs to optimize patient outcomes.Methods: A panel of dermatologists, clinical oncologists, and radiation oncologists developed an evidence-based algorithm for the prevention and treatment of cancer treatment-related cAEs using a skincare regimen that includes hygiene, moisturization, sun protection, and camouflage products.Results: The LACOM II algorithm discusses patient education before cancer treatment, appropriate skincare, triage, and the importance of treating emerging cAEs with a multidisciplinary team.Conclusions: Integrating proactive education, safe and effective skincare, triage, and reaction-specific management of cAEs is essential to optimize the care of patients living with cancer. The LACOM II algorithm provides evidence- and opinion-based best-practice recommendations to support clinicians working with oncology patients throughout the continuum of care, achieving optimal outcomes and improving patients' QoL. &nbsp.","PeriodicalId":15566,"journal":{"name":"Journal of Drugs in Dermatology","volume":"25 7","pages":"621-628"},"PeriodicalIF":2.2000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Drugs in Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.36849/JDD.9768","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Anticancer treatments are associated with cutaneous adverse events (cAEs) that can severely impact patients' quality of life (QoL) and interfere with treatment outcomes. LACOM aims to support clinicians in preventing and managing cAEs to optimize patient outcomes.

Methods: A panel of dermatologists, clinical oncologists, and radiation oncologists developed an evidence-based algorithm for the prevention and treatment of cancer treatment-related cAEs using a skincare regimen that includes hygiene, moisturization, sun protection, and camouflage products.

Results: The LACOM II algorithm discusses patient education before cancer treatment, appropriate skincare, triage, and the importance of treating emerging cAEs with a multidisciplinary team.

Conclusions: Integrating proactive education, safe and effective skincare, triage, and reaction-specific management of cAEs is essential to optimize the care of patients living with cancer. The LACOM II algorithm provides evidence- and opinion-based best-practice recommendations to support clinicians working with oncology patients throughout the continuum of care, achieving optimal outcomes and improving patients' QoL. .

查看原文本刊更多论文

拉丁美洲皮肤肿瘤管理（LACOM） II：管理肿瘤患者皮肤毒性的实用算法。

背景：抗癌治疗与皮肤不良事件（cAEs）相关，可严重影响患者的生活质量（QoL）并干扰治疗结果。LACOM旨在支持临床医生预防和管理cae，以优化患者预后。方法：由皮肤科医生、临床肿瘤学家和放射肿瘤学家组成的小组开发了一种基于证据的算法，用于预防和治疗与癌症治疗相关的cae，使用包括卫生、保湿、防晒和伪装产品在内的护肤方案。结果：LACOM II算法讨论了癌症治疗前的患者教育、适当的皮肤护理、分诊以及与多学科团队一起治疗新发cae的重要性。结论：将积极主动的教育、安全有效的护肤、分诊和针对cae的反应性管理相结合，对于优化癌症患者的护理至关重要。LACOM II算法提供基于证据和意见的最佳实践建议，以支持临床医生在整个治疗过程中与肿瘤患者一起工作，实现最佳结果并改善患者的生活质量。安康。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Drugs in Dermatology DERMATOLOGY-

CiteScore

2.20

自引率

13.30%

发文量

289

审稿时长

3-6 weeks

期刊介绍： The Journal of Drugs in Dermatology (JDD) is a peer-reviewed publication indexed with MEDLINE®/PubMed® that was founded by the renowned Dr. Perry Robins MD. Founded in 2002, it offers one of the fastest routes to disseminate dermatologic information and is considered the fastest growing publication in dermatology. We present original articles, award-winning case reports, and timely features pertaining to new methods, techniques, drug therapy, and devices in dermatology that provide readers with peer reviewed content of the utmost quality. Our high standards of content are maintained through a balanced, peer-review process. Articles are reviewed by an International Editorial Board of over 160 renowned experts.